{ "case_number": "CAC-UDRP-107802", "time_of_filling": "2025-08-26 09:25:49", "domain_names": [ "novartisneva.com" ], "case_administrator": "Olga Dvořáková (Case admin)", "complainant": [ " Novartis AG" ], "complainant_representative": "Abion GmbH", "respondent": [ "bijica3351 bijica3351 (bijica3351)" ], "respondent_representative": null, "factual_background": "

The Complainant, created in 1996 through a merger of two other companies Ciba-Geigy and Sandoz, is the holding company of the Novartis Group.  In 2024, The Novartis Group achieved net sales of USD 50.3 billion, and total net income amounted to USD 11.9 billion and employed approximately 76 000 full-time equivalent employees as of December 31, 2024. <\/span>

The Complainant informs that its <\/span>products are manufactured and sold in many countries worldwide, including in Russia, where it has an active presence through associated companies and subsidiaries, such as ООО «Новартис Нева» (that may be written in Latin alphabet as Novartis Neva LLC). The related Novartis group’s production site “Novartis Neva”, based in St. Petersburg, is designed for the production of solid dosage forms.<\/span><\/p>\n

The Complainant is the owner of the registered well-known trademark NOVARTIS in numerous jurisdictions all over the world. The Complainant´s trademark registrations predate the registration of the disputed domain name <novartisneva.com>, which was registered on April 3, 2025.<\/p>\n

 <\/p>\n

According to the Complainant, the disputed domain name is similar to its NOVARTIS trademark since it entirely incorporates the well-known distinctive trademark NOVARTIS combined with the word NEVA, which corresponds to part of the name of the Russian Novartis group’s production “Novartis Neva”.<\/p>\n

 <\/p>\n

The Complainant has not found that the Respondent is known by the disputed domain name. Indeed, when conducting searches on online trademark databases regarding the terms “novartisneva.com” or “novartisneva” or “novartis neva”, no information is found in relation to trademarks corresponding to the aforementioned terms. The Complainant argues that the Complainant trademarks predate the registration of the disputed domain name and that the Respondent has never been authorized by the Complainant to register the disputed domain name.<\/p>\n

 <\/p>\n

In the Complainant's view, given the strong presence of the Complainant and its NOVARTIS trademark on the market, it is implausible that the Respondent did not know them when it registered the disputed domain name.<\/p>\n

 <\/p>\n

In addition, the Complainant has shown that, at the time the Complainant found out about the disputed domain name, it resolved to a page simply announcing that the content of the website would have been added soon and that after (August 25, 2025) the disputed domain name resolved to a mere error page. Considering the above, the Complainant insists that there is no active website associated with the disputed domain name which constitutes passive holding of the disputed domain name.<\/p>\n

 <\/p>\n

The Complainant also sent a cease-and-desist letter to the Respondent, on April 7, 2025, informing the Respondent of the Complainant’s rights regarding the NOVARTIS trademark, to which the Respondent did not reply<\/p>\n

 <\/p>\n

Finally, the Complainant notes that the Respondent has provided incomplete contact details. Indeed, its mail address in the WhoIs record only contains the reference to the country and a postal code. The street and the city details are not provided. In the Complainant's view, it is likely that the Respondent has provided false WhoIs details.<\/p>", "other_legal_proceedings": "

The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>", "no_response_filed": "

The Complainant´s contentions are summarized above.<\/span><\/p>\n


No administratively compliant Response has been filed.<\/p>", "rights": "

The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>", "no_rights_or_legitimate_interests": "

The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>", "bad_faith": "

The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>", "procedural_factors": "

The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>", "decision": "Accepted", "panelists": [ "Guido Maffei" ], "date_of_panel_decision": "2025-09-25 00:00:00", "informal_english_translation": "

The Complainant is the owner of several trademarks for NOVARTIS. In particular, Novartis AG owns:<\/p>\n

\n
<\/div>\n
- International registration No. 663765 registered on July 1, 1996 and duly renewed for goods and services in classes 1, 2, 3, 4, 5, 7, 8, 9, 10, 14, 16, 17, 20, 22, 28, 29, 30, 31, 32, 40 and 42.  This trademark is protected in different countries including Russian Federation where the Respondent has its legal seat.<\/div>\n
<\/div>\n
- International registration No. 1349878 registered on November 29, 2016 for goods and services in classes 9, 10, 41, 42, 44 and 45.  This trademark is protected in different countries including Russian Federation where the Respondent has its legal seat.<\/div>\n
\n
<\/div>\n
- EU trademark No. 304857 registered on June 25, 1999 and duly renewed for goods and services in classes 1, 5, 9, 10, 29, 30, 31 and 32.<\/div>\n
<\/div>\n- US trademark No. 2336960 registered on April 4, 2000 and duly renewed for goods and services in classes 1, 5, 9, 10, 29, 30, 31, 32 and 42.<\/div>\n <\/div>", "decision_domains": { "novartisneva.com": "TRANSFERRED" }, "panelist": null, "panellists_text": null }